These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 20700784)

  • 21. An arsenal of magnetic nanoparticles; perspectives in the treatment of cancer.
    Karponis D; Azzawi M; Seifalian A
    Nanomedicine (Lond); 2016 Aug; 11(16):2215-32. PubMed ID: 27480599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnetic iron oxide nanoparticles as drug carriers: clinical relevance.
    El-Boubbou K
    Nanomedicine (Lond); 2018 Apr; 13(8):953-971. PubMed ID: 29376469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A smart magnetic nanoplatform for synergistic anticancer therapy: manoeuvring mussel-inspired functional magnetic nanoparticles for pH responsive anticancer drug delivery and hyperthermia.
    Sasikala AR; GhavamiNejad A; Unnithan AR; Thomas RG; Moon M; Jeong YY; Park CH; Kim CS
    Nanoscale; 2015 Nov; 7(43):18119-28. PubMed ID: 26471016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles.
    Liu Y; Miyoshi H; Nakamura M
    Int J Cancer; 2007 Jun; 120(12):2527-37. PubMed ID: 17390371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanomedicine and drug delivery.
    Wei C; Wei W; Morris M; Kondo E; Gorbounov M; Tomalia DA
    Med Clin North Am; 2007 Sep; 91(5):863-70. PubMed ID: 17826106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted nanoscale magnetic hyperthermia: challenges and potentials of peptide-based targeting.
    Fourmy D; Carrey J; Gigoux V
    Nanomedicine (Lond); 2015; 10(6):893-6. PubMed ID: 25867854
    [No Abstract]   [Full Text] [Related]  

  • 27. Magnetic Nanoparticles for Hepatocellular Carcinoma Diagnosis and Therapy.
    Ungureanu BS; Teodorescu CM; Săftoiu A
    J Gastrointestin Liver Dis; 2016 Sep; 25(3):375-83. PubMed ID: 27689203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor extracellular acidity-activated nanoparticles as drug delivery systems for enhanced cancer therapy.
    Du JZ; Mao CQ; Yuan YY; Yang XZ; Wang J
    Biotechnol Adv; 2014; 32(4):789-803. PubMed ID: 23933109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise.
    Bharali DJ; Mousa SA
    Pharmacol Ther; 2010 Nov; 128(2):324-35. PubMed ID: 20705093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticancer drug delivery with nanoparticles.
    Conti M; Tazzari V; Baccini C; Pertici G; Serino LP; De Giorgi U
    In Vivo; 2006; 20(6A):697-701. PubMed ID: 17203748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies.
    Soetaert F; Korangath P; Serantes D; Fiering S; Ivkov R
    Adv Drug Deliv Rev; 2020; 163-164():65-83. PubMed ID: 32603814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Programmable nanomedicine: synergistic and sequential drug delivery systems.
    Pacardo DB; Ligler FS; Gu Z
    Nanoscale; 2015 Feb; 7(8):3381-91. PubMed ID: 25631684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. pH-sensitive nano-systems for drug delivery in cancer therapy.
    Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
    Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer chemoprevention by polyphenols and their potential application as nanomedicine.
    Tabrez S; Priyadarshini M; Urooj M; Shakil S; Ashraf GM; Khan MS; Kamal MA; Alam Q; Jabir NR; Abuzenadah AM; Chaudhary AG; Damanhouri GA
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2013; 31(1):67-98. PubMed ID: 23534395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanomedicine: the promise and challenges in cancer chemotherapy.
    Naguib YW; Cui Z
    Adv Exp Med Biol; 2014; 811():207-33. PubMed ID: 24683034
    [No Abstract]   [Full Text] [Related]  

  • 36. Optimizing magnetic nanoparticle design for nanothermotherapy.
    Gazeau F; Lévy M; Wilhelm C
    Nanomedicine (Lond); 2008 Dec; 3(6):831-44. PubMed ID: 19025457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surface-active liposomes for targeted cancer therapy.
    Sofou S
    Nanomedicine (Lond); 2007 Oct; 2(5):711-24. PubMed ID: 17976032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biomedical nanomaterials for imaging-guided cancer therapy.
    Huang Y; He S; Cao W; Cai K; Liang XJ
    Nanoscale; 2012 Oct; 4(20):6135-49. PubMed ID: 22929990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thermoresponsive core-shell magnetic nanoparticles for combined modalities of cancer therapy.
    Purushotham S; Chang PE; Rumpel H; Kee IH; Ng RT; Chow PK; Tan CK; Ramanujan RV
    Nanotechnology; 2009 Jul; 20(30):305101. PubMed ID: 19581698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanomedicine in veterinary oncology.
    Lin TY; Rodriguez CO; Li Y
    Vet J; 2015 Aug; 205(2):189-97. PubMed ID: 25862394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.